Downregulation of EMX2 Is Associated With Clinical Outcomes in Lung Adenocarcinoma Patients
Clinical Lung Cancer - United States
doi 10.1016/j.cllc.2011.03.025
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2011
Authors
Publisher
Elsevier BV